Cognitive dysfunction is an important comorbidity of temporal lobe epilepsy (TLE). However, no targeted therapies are available and the mechanisms underlying cognitive impairment, specifically deficits in learning and memory associated with TLE remain unknown. Oxidative stress is known to occur in the pathogenesis of TLE but its functional role remains to be determined. Here, we demonstrate that oxidative stress and resultant processes contribute to cognitive decline associated with epileptogenesis. Using a synthetic catalytic antioxidant, we show that pharmacological removal of reactive oxygen species (ROS) prevents 1) oxidative stress, 2) deficits in mitochondrial oxygen consumption rates, 3) hippocampal neuronal loss and 4) cognitive dysfunction without altering the intensity of the initial status epilepticus (SE) or epilepsy development in a rat model of SE-induced TLE. Moreover, the effects of the catalytic antioxidant on cognition persisted beyond the treatment period suggestive of disease-modification. The data implicate oxidative stress as a novel mechanism by which cognitive dysfunction can arise during epileptogenesis and suggest a potential disease-modifying therapeutic approach to target it.
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Introduction
Epilepsy is increasingly recognized as a spectrum disorder characterized by chronic, spontaneous seizures (SRS). Temporal Lobe Epilepsy (TLE) is the most prevalent form of acquired epilepsy and is defined by the appearance of SRS after a precipitating brain event such as trauma, ischemic stroke or status epilepticus (SE). In addition to experiencing unpredictable seizures, patients with TLE and indeed all epilepsies, tend to suffer from debilitating comorbidities. Up to half of the people with epilepsy experience one or more psychiatric or cognitive comorbidities (Wiebe and Hesdorffer, 2007) . These comorbid conditions occur with epilepsy and impair quality of life. In fact, the burden of comorbidities can surpass those of the seizures themselves as quality of life correlates more with the comorbidities of epilepsy as opposed to the seizures alone (Gilliam et al., 2003) . Prominent among these comorbidities of epilepsy is cognitive impairment (Institute of Medicine, 2012). Currently available anti-seizure drugs control seizures in roughly 60% of patients; however, they often exacerbate comorbidities such as cognitive impairment, particularly deficits in memory (Helmstaedter and Kurthen, 2001; Helmstaedter et al., 2003) . Whereas the cognitive comorbidities of epilepsy are widely recognized for their frequent occurrence and debilitating nature, currently there are no targeted therapies to treat them or sufficient knowledge regarding their underlying mechanisms.
A growing body of research has implicated oxidative stress and mitochondrial dysfunction as contributing factors to numerous conditions with comorbid cognitive dysfunction including Alzheimer's disease (AD), Parkinson's disease (PD) and even normal aging (Butterfield, 2006; Lin and Beal, 2006) . Excessive production of reactive oxygen species (ROS) leads to elevated levels of cellular macromolecule oxidation contributing to cell dysfunction and cell death (Hensley et al., 1995) . ROS-induced neuronal death or processes underlying neuronal death could have a detrimental effect on areas of the brain controlling learning and memory processes such as the hippocampus, a brain region intimately associated with memory function. Samples obtained from patients with epilepsy show increased levels of oxidized proteins and lipids in serum, implicating oxidative stress as an ongoing process in these patients (Menon et al., 2012) . Data from our laboratory have demonstrated increased steady-state levels of reactive species and impaired glutathione redox status in the hippocampus in two separate TLE models including the pilocarpine model and the kainic acid model (Liang et al., 2000 (Liang et al., , 2008 (Liang et al., , 2012 Patel et al., 2001 Patel et al., , 2008 Ryan et al., 2014; Rowley et al., 2015) . Collectively, this work shows that oxidative Neurobiology of Disease 82 (2015) 289-297 
